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Background
Percutaneous interventional procedures offer diagnostic,
curative and palliative treatment options to patients with
cancer. Ultrasound (US) is an alternative guiding tech-
nique for various procedures including biopsy oflung,
spleen, soft tissue and bone, and procedures like tumor
ablation and abscess drainages among others. US has
advantages like versatility, availability, lesser cost and
time, lack of ionizing radiation and contrast media expo-
sure, and complete visualization of the needle track in real
time. This is a description of the various interventional
procedures performed at the Instituto Nacional de Can-
cerología under US guidance, its technical success and
complications.
Materials and methods
We retrospectively analyzed the procedures performed
under US guidance from January 2005 to October 2006.
No procedures performed on the mammary gland are
included. The diagnostic and therapeutic procedures per-
formed, its complications and the technical success are
described: quality of biopsy material for cyto-histological
diagnosis and success rate for completing the therapeutic
procedures. We compare our results with those published
in the medical literature.
Results
373 procedures were performed on 356 patients. The pro-
cedures were distributed as follow: A) biopsies: thyroid,
prostate, soft tissue masses, liver, transvaginal, diagnostic
thoracentesis and paracentesis, kidney, pancreas, muscle.
B) therapeutic interventions: thoracentesis, paracentesis,
transvaginal and retroperitoneal drainages, pelvic lym-
phocele sclerosis, hepatic radiofrequency ablation. Com-
plications: 18 patients with minor discomfort; 5 patients
with pain during transvaginal biopsies. No hospitaliza-
tion or specific intervention was needed. The cyto-his-
topathology results will be described in the final format.
Conclusion
US is a safe and reliable imaging method for guiding inter-
ventional diagnostic and therapeutic procedures in
patients with cancer.
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